Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer
Open Access
- 1 October 1992
- Vol. 70 (7) , 1880-1885
- https://doi.org/10.1002/1097-0142(19921001)70:7<1880::aid-cncr2820700713>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Symptomatic treatmentversus combination chemotherapy for patients with extensive non-small cell lung cancerCancer, 1991
- Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lungCancer, 1991
- Cancer statistics, 1991CA: A Cancer Journal for Clinicians, 1991
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.Journal of Clinical Oncology, 1990
- A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancerBritish Journal of Cancer, 1990
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.Journal of Clinical Oncology, 1988
- Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.Proceedings of the National Academy of Sciences, 1986
- A New International Staging System for Lung CancerChest, 1986
- Tests for trend in life table analysisBiometrika, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958